Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis-Reference-Cited by-同舟云学术

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis

Published:2017-08-04 Issue:8 Volume:3 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Deshpande Devyani¹,Srivastava Shashikant¹,Chapagain Moti¹,Magombedze Gesham¹^ORCID,Martin Katherine R.¹,Cirrincione Kayle N.¹^ORCID,Lee Pooi S.¹^ORCID,Koeuth Thearith¹^ORCID,Dheda Keertan²^ORCID,Gumbo Tawanda¹²

Affiliation:

1. Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX 75204, USA.

2. Lung Infection and Immunity Unit, Division of Pulmonology and University of Cape Town (UCT) Lung Institute, Department of Medicine, UCT, Observatory, 7925, Cape Town, South Africa.

Abstract

Ceftazidime-avibactam is highly efficacious against extensive- and multidrug-resistant strains of Mycobacterium tuberculosis .

Funder

Baylor Research Institute

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference47 articles.

1. Global control of tuberculosis: From extensively drug-resistant to untreatable tuberculosis;Dheda K.;Lancet Respir. Med.,2014

2. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis;Dheda K.;Lancet Respir. Med.,2017

3. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: A prospective cohort study;Dheda K.;Lancet Respir. Med.,2017